Werewolf Therapeutics, Inc. Common Stock

Go to Werewolf Therapeutics, Inc. Common Stock Website

$6.75

(%)
Live
Previous Close

$6.75

Day Range

$ - $

Previous Day Range

$ - $

Market Cap

$292.6 million USD

Day Vol.

Previous Day Vol.

Currency

USD

Primary Exchange

Nasdaq

Werewolf Therapeutics Inc is a biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer. It is leveraging its proprietary PREDATOR platform to design conditional...


Community
  • 0 posts discussing
0

Watchers

0

Visitors


Recent News

Company to present an update of its ongoing monotherapy and combination Phase 1/1b study of WTX-124 in advanced or metastatic solid tumors

Related tickers: HOWL.

Read Full Article

Werewolf Therapeutics (HOWL) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Related tickers: HOWL.

Read Full Article
Trending Tickers
DATS

XNAS

$1.24
(%)
LASE

XNAS

$2.10
(%)
NYCB

XNYS

$2.97
(%)
PACW

XNAS

$7.54
(%)
MLGO

XNAS

$0.00
(%)